02 August 2018
Visiongain’ has launched a new pharma report Global Bariatric Surgery Devices Market Forecast 2018-2028: Assisting Devices, Implantable Devices, Suturing Devices, Stapling Devices, Closure Devices, Trocars, Gastric Bands, Intragastric Balloons, Single Intragastric Balloons, Dual Intragastric Balloons, Triple Intragastric Balloons, Electrical Stimulation Devices, Gastric Emptying, Gastric Bypass, Sleeve Gastrectomy, Gastric Banding, Bariatric Surgery Clinics, Ambulatory Surgical Centres, Hospital Pharmacies
The bariatric surgery devices market is expected to witness a significant growth over the forecast period. The main drivers for the growth include rapid growth in the number of obese patients, growing incidences of obesity-related chronic disorders, and technological innovations in bariatric surgery systems. Additionally, government initiatives to curb obesity and related problems along with insurance coverage for bariatric procedures will further contribute to the growth of the market.
The lead analyst of the report commented “The demand for minimal invasive surgeries is growing rapidly as they save time, cost, and reduced hospital stay. In addition to this, governments are also encouraging the adoption of minimal invasive surgeries to lower the incidences of infection. Key players are striving to change the traditional methods of surgeries and developing innovative techniques to enable surgeons to perform bariatric surgeries more effectively.”
Leading companies featured in the report include Johnson & Johnson, Aspire Bariatrics, Inc.
GI Dynamics, Inc., Intuitive Surgical, Inc., Medtronic plc, Apollo Endosurgery, Inc., Mediflex, Cousin Biotech, Spatz FGIA Inc., The DACH Medical Group Holding AG (DACH), EnteroMedics Inc.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to email@example.com or call her on +44 (0) 207 336 6100
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Although price is still the most important competitive advantage for a biosimilar company, current discount rates are not enough to automatically convince the key stakeholders of a biosimilar’s value.
10 September 2019
The global anti-infective agents market is one that is driven by innovation. This is vital for maintaining the rich pipeline of anti-infective agents seen in the market today.
09 September 2019
Thyroid disease is one of today’s most prevalent hormonal illnesses. Hyperthyroidism, hypothyroidism, and thyroid nodules are the most common thyroid gland disorders.
05 September 2019
Somatostatin was used to diagnose gastrointestinal tract tumors and acromegaly in the clinical environment.